Montesinos Mónica S, Satterfield Rachel, Young Samuel M
Research Group Molecular Mechanisms of Synaptic Function, Max Planck Florida Institute for Neuroscience, Jupiter, FL, 33458, USA.
Methods Mol Biol. 2016;1474:73-90. doi: 10.1007/978-1-4939-6352-2_5.
Neuroscience research has been revolutionized by the use of recombinant viral vector technology from the basic, preclinical and clinical levels. Currently, multiple recombinant viral vector types are employed with each having its strengths and weaknesses depending on the proposed application. Helper-dependent adenoviral vectors (HdAd) are emerging as ideal viral vectors that solve a major need in the neuroscience field: (1) expression of transgenes that are too large to be packaged by other viral vectors and (2) rapid onset of transgene expression in the absence of cytotoxicity. Here, we describe the methods for large-scale production of HdAd viral vectors for in vivo use with neurospecific transgene expression.
重组病毒载体技术在基础、临床前和临床水平上彻底改变了神经科学研究。目前,多种重组病毒载体类型被应用,每种类型根据其预期应用都有优缺点。辅助依赖型腺病毒载体(HdAd)正成为解决神经科学领域主要需求的理想病毒载体:(1)表达因太大而无法被其他病毒载体包装的转基因;(2)在无细胞毒性的情况下转基因表达快速起效。在此,我们描述用于体内神经特异性转基因表达的HdAd病毒载体大规模生产方法。